A Star-Laden Biotech SPAC Worth Considering

In this video from Motley Fool Live, recorded on March 22, Fool.com contributors Brian Orelli and Keith Speights discuss the prospects for Revolution Health Acquisition Corp. (NASDAQ: REVH.U). The healthcare-focused special purpose acquisition company (SPAC) is sponsored by ARCH Ventures and General Catalyst and has some solid leadership at the helm, including former CEO of Vertex (NASDAQ: VRTX) Jeffrey Leiden who serves as the SPAC's chairman.

Continue reading

Source Fool.com